Tiludronic acid can be detected in blood and urine samples from Thoroughbred racehorses over 3 years after last administration.

Abstract

Administration of bisphosphonates, including tiludronic acid, to Thoroughbred racehorses below 3 and a half years of age is prohibited in most racing jurisdictions. To determine if evidence of administration of tiludronic acid could be obtained from analysis of blood and urine samples beyond 40days after administration. Retrospective cohort. Horses maintained in a highly controlled environment and treated with Tildren®a were selected from clinical records. Twenty-four horses were identified, 21 of which were still in race training. Blood and urine samples were collected and analysed for the presence of tiludronic acid using ultra-high-performance liquid chromatography-high-resolution mass spectrometry. Tiludronic acid was detected in samples from every horse, including two that had been given a therapeutic dose of the drug 3years prior to sample collection. The estimated concentrations of tiludronic acid in the blood collected at least 2years post-administration were consistently very low (less than 0.3ng/mL). The estimated concentrations in urine were less consistent and were generally lower than those in blood, although higher levels were inconsistently detected in individual horses (up to about 16ng/mL almost 1year post-administration in 1 horse and about 3.7ng/mL at almost 3years post-administration in another). The study was performed in horses that are older than the primary target group. A single sample was obtained from most horses and so we cannot comment on elimination profiles. Evidence that a therapeutic dose of tiludronic acid has been administered to a horse can be obtained from detection of the drug in blood and urine samples over 3years after it was administered.